Cbio announces drug manufacture success
12 June, 2002 by Melissa TrudingerCbio announced at the Bio 2002 conference in Toronto that it had successfully manufactured its first drug, called Early Pregnancy Factor (EPF), and was on track to start its first clinical trials next year.
US deal puts Axon on track for new screening product
11 June, 2002 by Tanya HollisInstrumentation and software developer Axon Instruments has signed an exclusive deal with the US maker of an electrode device that can be used to scan potential drugs for use in heart disease, chronic pain, diabetes, high blood pressure and migraine.
Biotron R&D effort boosted by Waters deal
11 June, 2002 by Melissa TrudingerInstrumentation company Waters Australia will be assisting Canberra-based Biotron in its CT-1 cancer biomarker project, according to details of a new collaboration.
Norwood Abbey patent success
11 June, 2002 by Tanya HollisAustralian technology enabling the collection of intracellular fluid for analyte measurement without the use of a needle has gained a United States patent.
A new name for MicroMedical
07 June, 2002 by Tanya HollisArtificial heart developer MicroMedical Industries has announced it plans to change its name to Ventracor.
Farmacule sets down roots for new technology
07 June, 2002 by Pete YoungA two-pronged business strategy is showing promise for Australia's leading player in molecular farming, Farmacule Bioindustries.
Anadis claims oral vaccine delivery breakthrough
06 June, 2002 by Melissa TrudingerClaims of a breakthrough technique for delivering oral vaccines and pharmaceuticals to the stomach wall have been made by Melbourne company Anadis.
No GE-free zones for Victoria
06 June, 2002 by Melissa TrudingerAgriculture Victoria has confirmed that it will not be seeking to create genetic engineering-free (GE-free) zones in Victoria, at least for the time being.
EpiTan signs with US group to develop formula
06 June, 2002 by Tanya HollisTanning drug developer EpiTan has signed a collaborative agreement with a United State research institute to create a sustained-release version of its formulation.
Device network, AusBiotech join forces
06 June, 2002 by Melissa TrudingerThe Medical Device Network (MDN) has joining forces with peak body AusBiotech to officially become a program of the industry organisation.
OTGR gets tough on GM field trials
05 June, 2002 by Melissa TrudingerThe Office of the Gene Technology Regulator (OGTR) has moved to tighten procedures for post-harvest monitoring and strengthen the management of GM field trials performed under the new regulatory system.
EvoGenix partners with BresaGen
04 June, 2002 by Iain ScottBiotech start-up EvoGenix has teamed with Adelaide-based company BresaGen to work on a protein biopharmaceutical project.
New procedure for those that kneed it
04 June, 2002 by Claire DobleA new procedure for knee replacement, in which cultured cartilage cells grow themselves into place, is available now for Australian patients.
Antisense offers key to new MS treatment
04 June, 2002 by Melissa TrudingerA new way to treat multiple sclerosis (MS) with antisense drugs is being developed by Melbourne company Antisense Therapeutics with the assistance of its US partner Isis Pharmaceuticals.
Eye researcher wins award
04 June, 2002 by Tanya HollisDedication to warding off a common form of blindness has earned a Melbourne ophthalmologist the 2002 Amgen Medical Researcher Award.
